Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/02/2012CN102429951A Flavone-saponin extract of humifuse euphorbia herb and application thereof
05/02/2012CN102429941A Method for decocting pseudo-ginseng root in gynaecologic revival pill
05/02/2012CN102429935A Brucea fruit oil self-emulsifying preparation and preparation method thereof
05/02/2012CN102429932A Method for extracting lucid ganoderma essence
05/02/2012CN102429916A Substances mixture, use and infusion solution
05/02/2012CN102429915A Application of natural compound P44 in inhibiting activation of reproduction and growth of tumour cells
05/02/2012CN102429914A Compound preparation having anti-tumor action
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429907A Agent for overcoming resistance to anti-cancer agent
05/02/2012CN102429900A Application of natural compound P25 in inhibiting reproduction and growth of tumour cells
05/02/2012CN102429898A Application of natural compound P47 in inhibiting reproduction and growth of tumour cells
05/02/2012CN102429897A Pharmaceutical composition for improving oral bioavailability of morin
05/02/2012CN102429895A Application of natural compound P48 in inhibition of tumor cell reproduction and growth
05/02/2012CN102429890A Medicinal composition containing cells and application thereof
05/02/2012CN102429889A Large ring lactone type medicament capsule and preparation method thereof
05/02/2012CN102429888A Water-soluble resveratrol effervescent tablet and preparation method thereof
05/02/2012CN102429880A Dasatinib tablet
05/02/2012CN102429878A Calcium folinate for injection and production technology for calcium folinate
05/02/2012CN102429877A Double-targeting-function medicament sustained-release system prepared by supercritical fluid technique
05/02/2012CN102429870A Novel tumor-targeting arboraceous polymer nano carrier of camptothecin drug
05/02/2012CN102429869A Preparation method of stearic acid drug-loading micro-nanoparticle loaded with drug with controllable packing degree
05/02/2012CN102429868A Liposome medicinal composition with tumor targeting, in-vivo tracing and treating functions and preparation method thereof
05/02/2012CN102205035B Traditional Chinese medicine for treating gastric cancer
05/02/2012CN102178669B Application of oleic acid to preparation of anti-HPV (Human Papilloma Virus) drugs
05/02/2012CN102178668B Application of linoleic acid in preparing human papillomavirus (HPV) resisting medicament
05/02/2012CN102106833B Pemetrexed disodium freeze-dried powder injection and preparation method thereof
05/02/2012CN101966255B Chinese medicinal composition for treating mammary gland hyperplasia and breast cancer and preparation method thereof
05/02/2012CN101928254B Benzotriazole derivatives and preparation method and use thereof
05/02/2012CN101897839B Comprehensive utilization method of banana stalks
05/02/2012CN101891836B Method for extracting white mushroom lentinan assisted with ultrasonic wave
05/02/2012CN101869605B Method for extracting and separating mulberry leaf flavone and alkaloid composite
05/02/2012CN101869588B Preparation method and application of effective component of chrysanthemum
05/02/2012CN101812059B Nitric oxide donor-type farnesyl thiosalicylic acid derivative, and preparation method and medical application thereof
05/02/2012CN101808636B Treatment of melanoma
05/02/2012CN101797247B Application of isoflavone compound in preparation of anti-tumor drug or food
05/02/2012CN101760475B Recombinant retroviral vector
05/02/2012CN101757056B Extract of yangtao actinidia root and preparation method and applications thereof
05/02/2012CN101671669B Hepatocellular carcinoma targeting gene expression element AE and applications thereof
05/02/2012CN101558870B Mulberry and sea backthern concentrated food
05/02/2012CN101555241B Ampelopsin pro-dug and preparing method and application thereof
05/02/2012CN101519437B Cyclic heptapeptide compound in Hsisha sponge and application thereof
05/02/2012CN101495482B Aziridinyl-epothilone compounds
05/02/2012CN101480415B Cordyceps sinensis sustained and controlled release capsule and preparation method thereof
05/02/2012CN101375938B Cudrania tricuspidata extract, preparation and application thereof
05/02/2012CN101370791B Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
05/02/2012CN101365723B Antibodies directed to her-3 and uses thereof
05/02/2012CN101347493B Use of shamrock extract in preparing anti-tumor medicament
05/02/2012CN101347433B Pharmacy use of 4-aniline quinazoline derivatives
05/02/2012CN101343265B Extraction method of effective ingredients of cave flower
05/02/2012CN101316593B Formulations of quinolinones
05/02/2012CN101284860B Antineoplastic pharmaceutical compositions, preparation method and applications thereof
05/02/2012CN101056868B Substituted chroman derivatives, medicaments and use in therapy
05/02/2012CN101045156B Special target medicine and its use
05/01/2012US8168803 Methods of using [3.2.0] heterocyclic compounds and analogs thereof
05/01/2012US8168776 Method for making a 21 nucleotide double stranded RNA chemically linked at one end
05/01/2012US8168647 Vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
05/01/2012US8168643 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168628 Conjugated psychotropic drugs and uses thereof
05/01/2012US8168610 Bispecific oligonucleotide for the treatment of CNS malignancies
05/01/2012US8168583 2-fluoronucleosides
05/01/2012US8168392 Tetrahydrofolate synthetase gene
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168184 Bi-specific monoclonal antibody (specific for both CD3 and CD11B) therapeutic drug
05/01/2012US8168180 Methods and compositions for modulating angiogenesis
05/01/2012US8168179 Treatment method using anti-PD-L1 antibody
05/01/2012CA2665539C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/01/2012CA2583910C Angiopoietin-2 specific binding agents
05/01/2012CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
05/01/2012CA2508831C Immunoconjugates with an intracellularly-cleavable linkage
05/01/2012CA2493789C Anthranyl derivatives having an anti cholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
05/01/2012CA2493402C Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same
05/01/2012CA2478902C Methods for treating mammary gland disorders
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2455633C Sustained-release therapeutic bioadhesive systems
05/01/2012CA2439604C N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
05/01/2012CA2404212C A process for the preparation of epothilone analogs and intermediates
05/01/2012CA2333466C Gbs toxin receptor
04/2012
04/26/2012WO2012054929A2 Use of human serum albumin to decrease antigenicity of therapeutic proteins
04/26/2012WO2012054792A2 Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells
04/26/2012WO2012054717A2 Detecting and treating solid tumors through selective disruption of tumor vasculature
04/26/2012WO2012054698A1 Crystalline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phthalazin-3(7h)-one tosylate salt
04/26/2012WO2012054564A2 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
04/26/2012WO2012054333A2 Methods for identifying inhibitors of abeta42 oligomers
04/26/2012WO2012053928A1 Immunologically active substance, process for preparing same, bioprobe, pharmaceutical composition, diagnostics and treatment methods
04/26/2012WO2012053862A2 Composition comprising a red garlic extract for preventing or treating diseases caused by respiratory apoptosis
04/26/2012WO2012053787A2 Aryloxy phenoxy acrylic compound having hif-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
04/26/2012WO2012053768A2 Aryloxyphenoxyacetyl-based compound having hif-1 inhibition activity, preparation method thereof and pharmaceutical composition containing the same as an active ingredient
04/26/2012WO2012053741A2 Nucleic acid molecules inducing rna interference, and uses thereof
04/26/2012WO2012053630A1 Antagonist for mutated androgen receptor
04/26/2012WO2012053606A1 Arylaminoheterocyclic carboxamide compound
04/26/2012WO2012053206A1 Wdhd1 peptides and vaccines including the same
04/26/2012WO2012052898A1 Lipid vectors delivering gene silencers
04/26/2012WO2012052843A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies
04/26/2012WO2012052753A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
04/26/2012WO2012052745A1 Combinations of pi3k inhibitors with a second anti -tumor agent
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 2211